The French pharmaceutical company claims that Sarclisa-VRD showed great improvement in the minimum residual disease (MRD) ...

Funds should be able to invest more in promising local innovations, keeping IP in Australia and boosting productivity while ...

Sanofi India Limited ( ($IN:SANOFI) ) has issued an update. Sanofi India Limited reported a 2% decline in net sales year-to-date but achieved a 6% ...

Foreign firms showed mixed reactions to the decision, with some willing to offload a 5% stake while others were not ...

Regeneron develops, manufactures, and markets medicines for serious diseases with a primary focus on immunology, ophthalmology, oncology, and rare conditions. Its scientific model centers on a robust ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...